Evidence map›Paper›PMID 35079887›Full record

ArticleEuropean radiology2022

Intratumoral and peritumoral radiomics based on dynamic contrast-enhanced MRI for preoperative prediction of intraductal component in invasive breast cancer.

Hao Xu, Jieke Liu, Zhe Chen, Chunhua Wang, Yuanyuan Liu, Min Wang, Peng Zhou, Hongbing Luo, Jing Ren

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hao Xu *Department of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Jieke Liu *Department of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Zhe ChenDepartment of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Chunhua WangDepartment of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Yuanyuan LiuDepartment of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Min WangDepartment of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Peng ZhouDepartment of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Hongbing LuoDepartment of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. rohbin@163.com.
Jing RenDepartment of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. 13880611648@163.com.ORCID http://orcid.org/0000-0003-1600-8085
University of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo develop and validate radiomic models for preoperative prediction of intraductal component in invasive breast cancer (IBC-IC) using the intratumoral and peritumoral features derived from dynamic contrast-enhanced MRI (DCE-MRI).

methodsThe prediction models were developed in a primary cohort of 183 consecutive patients from September 2017 to December 2018, consisting of 45 IBC-IC and 138 invasive breast cancers (IBC). The validation cohort of 111 patients (27 IBC-IC and 84 IBC) from February 2019 to January 2020 was enrolled to test the prediction models. A total of 208 radiomic features were extracted from the intratumoral and peritumoral regions of MRI-visible tumors. Then the radiomic features were selected and combined with clinical characteristics to construct predicting models using the least absolute shrinkage and selection operator. The area under the curve (AUC) of receiver operating characteristic, sensitivity, and specificity were used to evaluate the performance of radiomic models.

resultsFour radiomic models for prediction of IBC-IC were built including intratumoral radiomic signature, peritumoral radiomic signature, peritumoral radiomic nomogram, and combined intratumoral and peritumoral radiomic signature. The combined intratumoral and peritumoral radiomic signature had the optimal diagnostic performance, with the AUC, sensitivity, and specificity of 0.821 (0.758-0.874), 0.822 (0.680-0.920), and 0.739 (0.658-0.810) in the primary cohort and 0.815 (0.730-0.882), 0.778 (0.577-0.914), and 0.738 (0.631-0.828) in the validation cohort.

conclusionsThe radiomic model based on the combined intratumoral and peritumoral features from DCE-MRI showed a good ability to preoperatively predict IBC-IC, which might facilitate the individualized surgical planning for patients with breast cancer before breast-conserving surgery. KEY POINTS: •·Preoperative prediction of intraductal component in invasive breast cancer is crucial for breast-conserving surgery planning. • Peritumoral radiomic features of invasive breast cancer contain useful information to predict intraductal components. •·Radiomics is a promising non-invasive method to facilitate individualized surgical planning for patients with breast cancer before breast-conserving surgery.

Indexed as

Breast NeoplasmsFemaleHumansMagnetic Resonance ImagingNomogramsRetrospective StudiesROC CurveBreast neoplasmsCarcinoma, intraductal, noninfiltratingDiagnostic imagingMagnetic resonance imaging

Identifiers

PMID35079887
OpenAlexW4207052052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.